Bing

SEARCH HISTORY

The U.S. Food and Drug Administration (FDA) declined to approve Northera, CHTP’s blood pressure treatment, in 2012. CHTP resubmitted the drug in September. A research note from analysts at Wedbush indicated that an FDA advisory panel recently …
Investor Place · ByChristopher Freeburn · 1/16/2014
The 91.74% gain in Chelsea Therapeutics International Ltd (Nasdaq: CHTP) stock yesterday (Wednesday) is the latest biotech to see a massive one-day surge. More development-stage biotechs are nearing approval for new treatments – and doubling or …
Money Morning · ByDiane Alter · 1/16/2014
This reverses the recent trend for CHTP, as the stock is now up over 12% since Jan 15. This pharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings …
Yahoo Finance · 2/14/2014
More from Bing News
After Rockwell Medical Inc (NASDAQ:RMTI) stock was lifted to Buy and price target $22 at Chardan Capital Markets. Rockwell Medical Inc (NASDAQ:RMTI) shares rose 5.99%, to end at $11.15. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) …
fxnewscall.com · 12/20/2013
Investors like to buy the stocks at a rock bottom price that have growth potential ... Chelsea Therapeutics International Ltd (NASDAQ:CHTP): Chelsea Therapeutics is a development stage pharmaceutical company that focuses on acquiring, developing and ...
Seeking Alpha · 5/11/2012
Chelsea Therapeutics International Ltd. ( CHTP) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the …
NASDAQ · 2/14/2014
Boston, MA 02/19/2014 (wallstreetpr) – Chelsea Therapeutics International Ltd (NASDAQ:CHTP) received the best news it could have wished for,with the approval of its Northera drug that has been developed to treat neurogenic ortostatic hypotension, which ...
wallstreetpr.com · 2/19/2014
Wedbush believed that Chelsea Therapeutics International is an attractive acquisition or partnership target for multiple pharmaceutical companies because of the approval of Northera The stock price of Chelsea Therapeutics International Ltd. (CHTP ...
The Street · 3/15/2014
Charlotte NC-based Chelsea Therapeutics (NASDAQ:CHTP, Stock Forum) has announced its Northera (droxidopa) product has won accelerated approval by the US Food and Drug Administration (FDA). A decision regarding approval of the drug was …
Stockhouse · 2/18/2014
Chelsea Therapeutics (Nasdaq: CHTP) 33.3% HIGHER; the FDA granted accelerated approval of NORTHERATM (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). NORTHERA is the first and only therapy approved by …
StreetInsider · 2/18/2014